Successful completion of EIC Accelerator project

We are proud recipients of the prestigious EIC (European Innovation Council) Accelerator Grant, awarded in 2020 to support the development of IscAlert™. Being part of this esteemed program within the European innovation and entrepreneurship ecosystem has been truly rewarding.

Throughout this project, significant deliverables have been achieved. Our clinical studies have demonstrated IscAlert's efficacy as a safe and dependable monitor for ischemia, providing continuous and real-time measurements. The process for obtaining CE marking approval as a Class IIa medical device for IscAlert is underway with a Notified Body, and the audit process is progressing as planned. Furthermore, numerous clinical studies were initiated in 2023, with additional approvals secured for projects planned to start in 2024.

Our efforts have encompassed diverse areas including clinical trials, regulatory compliance, product development and optimization, and scaling up production processes.

With these accomplishments, we are on track to introduce IscAlert to the market— the world's first CO2 sensor designed for the earliest possible detection of ischemia.

Sensocure AS Norway Health Tech #innovation #innovationinprogress #medicaldevice #sensortechnology #eicaccelerator